Ad is loading...
JVAYX
Price
$43.11
Change
-$0.03 (-0.07%)
Updated
Nov 15 closing price
RMFCX
Price
$58.23
Change
-$0.50 (-0.85%)
Updated
Nov 15 closing price
Ad is loading...

JVAYX vs RMFCX

Header iconJVAYX vs RMFCX Comparison
Open Charts JVAYX vs RMFCXBanner chart's image
JPMorgan Value Advantage R6
Price$43.11
Change-$0.03 (-0.07%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$58.23
Change-$0.50 (-0.85%)
VolumeN/A
CapitalizationN/A
JVAYX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVAYX vs. RMFCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVAYX is a Buy and RMFCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. JVAYX (9.47B). RMFCX (1.69) and JVAYX (1.63) have matching dividends . JVAYX was incepted earlier than RMFCX: JVAYX (8 years) vs RMFCX (22 years). RMFCX (25.00) and JVAYX (24.00) have comparable annual turnover. RMFCX has a lower initial minimum investment than JVAYX: RMFCX (250) vs JVAYX (15000000). JVAYX annual gain was more profitable for investors over the last year : 25.28 vs. RMFCX (21.31). RMFCX return over 5 years is better than : 44.92 vs. JVAYX (22.83).
JVAYXRMFCXJVAYX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD21.53916.440131%
Front LoadN/AN/A-
Min. Initial Investment150000002506,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.47B104B9%
Annual Yield % from dividends1.631.6997%
Returns for 1 year25.2821.31119%
Returns for 3 years-2.7115.46-18%
Returns for 5 years22.8344.9251%
Returns for 10 yearsN/A65.01-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS0.630.01
+1.10%
Momentus
WWW21.79-0.24
-1.09%
Wolverine World Wide
SNAP10.60-0.16
-1.49%
Snap
SHC14.31-0.68
-4.54%
Sotera Health Company
ENTA9.53-0.60
-5.92%
Enanta Pharmaceuticals